Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Chemoresistance and plasticity of tumor-initiating stem-like cells (TICs) promote tumor recurrence and metastasis. The gut-originating endotoxin-TLR4-NANOG oncogenic axis is responsible for the genesis of TICs. This study investigated mechanisms as to how TICs arise through transcriptional, epigenetic, and post-transcriptional activation of oncogenic TLR4 pathways. Here, we expressed constitutively active TLR4 () in mice carrying pLAP-tTA or pAlb-tTA, under a tetracycline withdrawal-inducible system. Liver progenitor cell induction accelerated liver tumor development in caTLR4-expressing mice. Lentiviral shRNA library screening identified histone H3K4 methylase SETD7 as central to activation of TLR4. SETD7 combined with hypoxia induced TLR4 through HIF2 and NOTCH. LIN28 post-transcriptionally stabilized TLR4 mRNA via de-repression of microRNA. These results supported a LIN28-TLR4 pathway for the development of HCCs in a hypoxic microenvironment. These findings not only advance our understanding of molecular mechanisms responsible for TIC generation in HCC, but also represent new therapeutic targets for the treatment of HCC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025994PMC
http://dx.doi.org/10.1016/j.isci.2023.106254DOI Listing

Publication Analysis

Top Keywords

histone h3k4
8
h3k4 methylase
8
tumor-initiating stem-like
8
stem-like cells
8
tlr4
6
lin28 histone
4
methylase induce
4
induce tlr4
4
tlr4 generate
4
generate tumor-initiating
4

Similar Publications

Canonical and Non-Canonical Functions of Histone H3K4 Methylation Modifiers in Cancer.

Cancer Sci

September 2025

Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Histone H3K4 modifications are altered in the regulation of gene expression and in multiple cellular processes during cancer development and progression. Understanding the roles of H3K4-modifying enzymes will provide novel insights into therapeutic tools for cancer treatment. H3K4-modifying enzymes catalyze the addition or removal of covalent modifications with specific substrate preferences.

View Article and Find Full Text PDF

Human opsin restoration by histone methylation using methyltransferase fusion protein SETD7-dCas9.

Mol Ther Nucleic Acids

September 2025

Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si, Gyeonggi-do 17104, Republic of Korea.

Epigenetic modulation enables precise gene regulation without altering DNA sequences. While histone acetylation has been widely utilized for gene activation, the therapeutic potential of histone methylation remains underexplored. In this study, we developed a new epigenetic activator by fusing the histone methyltransferase SETD7 to deactivated Cas9 (dCas9).

View Article and Find Full Text PDF

Toxicological insights into hydrogen sulfide biology in : detection, metabolism, and functional outcomes.

Crit Rev Toxicol

September 2025

Department of Preventive Medicine and Public Health Laboratory Science, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China.

Hydrogen sulfide (HS), while historically recognized as a poisonous substance, also serves as a gasotransmitter that mediates a wide spectrum of physiological processes across species and is involved in the mechanisms of various exogenous toxicants. The is a valuable tool in toxicology, featuring both a conserved enzymatic HS metabolic pathway and a unique dietary bacteria-derived HS generation mechanism. Notably, existing data demonstrate that HS can extend lifespan, strengthen stress resistance, and preserve mitochondrial function in .

View Article and Find Full Text PDF

SET7/9 exhibits sigmoidal kinetics on nucleosomes, hyperbolic kinetics on histones by an ordered sequential mechanism and methylates lysine and arginine.

J Biol Chem

August 2025

Pharmaceutical analysis Laboratory, College of Pharmacy, University of Manitoba, 750 McDermot Avenue West, Winnipeg, Manitoba, R3E 0T5, Canada; Paul Albrechtsen Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada. Electronic address:

SET7/9 (SETD7) is a SET domain protein lysine methyltransferase (PKMT). We characterized its activity using a mass spectrometry (MS) assay showing that it follows an ordered sequential enzyme kinetic mechanism where SAM is the first substrate to bind followed by histone H3, and mono-methylated histone H3 is the first product to dissociate, followed by SAH. Full-length histones H2A, H2B and H4 are also substrates for SET7/9.

View Article and Find Full Text PDF

The Complex Proteins Associated with Set1 (COMPASS)-like complex regulates developmental gene expression via histone 3 lysine 4 (H3K4) methylation and other transcriptional mechanisms. Several members of the lysine methyltransferase 2C and D (KMT2C/D)-COMPASS-like complex are implicated in human congenital heart and vascular defects. The investigation of the orthologous Trithorax-related (Trr)-COMPASS-like complex in (the fruit fly) offers a versatile model to explore gene function in the developing heart.

View Article and Find Full Text PDF